Tables at a glance

Table 1

Table 2

Table 3

Table 4

Table 5

Figures at a glance

Comments

Figure 1

Table 1

N = 67
Age	3.23 (1-17) años
Sex (female)	40 (59%)
Down syndrome	41 (61%)
Rastelli classification Tipe A Tipe B Tipe C	60 (89%) 5 (7.4%) 2 (2.9%)
NYH functional class II III	85% 15%
LVEF %	66 (33-77)
Pulmonary artery banding	7 (10.4%)

Table 1: Pre-Surgical Characteristics

Table 2

N = 67
Surgical technique Unipatch Modified unipatch 2 patches	57 (85 %) 7 (10.4%) 3 (4.4%)
Aortic clamping time	81 (30-133)
Extracorporeal circulation time	121 (58 -296)
Morbidity < 30 days	9 (13.4%)
Mortality	3 (4.4%)

Table 2: Surgical Characteristics

Table 3

N = 55
Follow-up (years)	4.7 (1 – 14)
Morbidity > 30 days	5 (7.4%)
AV valve reoperations	4 (7.2%)
Pacemaker implants	9 (16.3%)
Current treatment None Sildenafil Diuretic	14 (25.4%) 3 (5.4%) 41 (74.5%)
Antihypertensive Digoxin	21 (38%) 3 (5.4%)

Table 3: Follow-up

Table 4

N° 67	Preop	Postop	Follow-up N° 54	P value
PASP - Normal - Mild - Moderate - Severe	68.9 (28-105) 3 (4.4%) 2 (2.9%) 8 (11.9%) 48 (71.6%)	31.9 (16 – 75) 50 (74%) 9 (13.4%) 5 (7.4%) 4 (5.9%)	34 (13-76) 38 (70%) 9 (16.6%) 4 (7.4%) 3 (5.5%)	0.0001 0.054 0.29 0.0001

Sources: derived by the author from FIES, various issues, the TMI model.

Table 4: Measurement of Pulmonary Artery Systolic Pressure (mmHg)

Table 5

	Pulmonary resistance < 6 UW/m2 14 (29%)	Pulmonary resistance > 6 UW/m2 34 (71%)	P Value
Down syndrome	6 (42%)	15 (44%)	6 (42%)
Central Valve regurgitation	6 (42%)	14(41%)	6 (42%)
Reinterventions	1 (7%)	-	1 (7%)
Mortality	-	4 (11%)	-

Table 5: Patients with Low and High but Mobile Pulmonary Resistances

FIGURE 1

Figure 1: Diagnostic catheterization